Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 6/20 | 0.64 |
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | LPL | P06858 | 2/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | F11 | P03951 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL806832 | 1.00 | ENPP2 (0.64) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL708054 | 0.90 | ENPP2 (0.59) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL806834 | 0.89 | ENPP2 (0.58) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL15459217 | 0.88 | ENPP2 (0.52) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL15459216 | 0.88 | ENPP2 (0.52) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL6850798 | 0.81 | ENPP2 (0.50) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL20503842 | 0.81 | ENPP2 (0.48) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL204921 | 0.80 | ENPP2 (0.73) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL29167102 | 0.79 | LPL (0.78) | ENPP2CA2CA1LPLLIPG | |
| SCHEMBL25590575 | 0.79 | ENPP2 (0.44) | ENPP2CA2CA1LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11213800-B2 | Covalent organic framework films, and methods of making and uses of same | CORNELL UNIVERSITY (US) | 2022-01-04 | — | — | US | disclosed |
| US-20150291870-A1 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | ARKEMA INC. | 2015-10-15 | — | — | US | disclosed |
| US-20150291870-A1 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | ARKEMA INC. | 2015-10-15 | — | — | US | disclosed |
| US-20140148596-A1 | Covalent Organic Frameworks and Methods of Making Same | CORNELL UNIVERSITY (US) | 2014-05-29 | — | — | US | disclosed |
| US-20140037944-A1 | COVALENT ORGANIC FRAMEWORK FILMS, AND METHODS OF MAKING AND USES OF SAME | CORNELL UNIVERSITY (US) | 2014-02-06 | — | — | US | disclosed |
| WO-2012037090-A2 | COVALENT ORGANIC FRAMEWORK FILMS, AND METHODS OF MAKING AND USES OF SAME | CORNELL UNIVERSITY (US) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291870-A1 | ADSORPTION SYSTEMS USING METAL-ORGANIC FRAMEWORKS | PFAS, CHIA, PARN | ENPP2 4813/4885CA2 71/4885CA1 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.